Annovis Bio, Inc.

NYSE:ANVS

Biotechnology

Healthcare
$1.21 +0.00%

+$0.00 today

Market cap
$51.64M
Beta
1.24
P/E (TTM)
-1.1
EPS (TTM)
-$1.47
52W Low $1.54High $5.50

Volume 1.35M

Average 1.08M

Balance Sheet

Inspect the capital base behind the business.

Assets

$21.08M

FY 2025 · Annual

+51.4% YoY

Liabilities

$4.23M

FY 2025 · Annual

-8.4% YoY

Equity

$16.85M

FY 2025 · Annual

+81.0% YoY

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents45.69M28.38M5.75M10.55M19.53M
Short-term Investments00000
Net Receivables00000
Inventory00000
Other Current Assets9.87K7.54M20.8K7.5K7.5K
Total Current Assets46M36.02M10.21M13.93M21.08M
Property, Plant & Equipment (Net)00000
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets00000
Total Non-current Assets00000
Total Assets46M36.02M10.21M13.93M21.08M
Account Payables688.07K3.96M1.29M2.31M2.59M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities105.67K02731.21M618.66K
Total Current Liabilities1.51M7.7M4.28M3.88M3.64M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0013.68M737K595K
Total Non-current Liabilities0013.68M737K595K
Total Liabilities1.51M7.7M17.96M4.62M4.23M
Common Stock8108161.05K1.41K2.72K
Retained Earnings(28.73M)(54.05M)(110.26M)(134.85M)(163.7M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity44.49M28.32M(7.75M)9.31M16.85M
Total Debt00000
Net Debt(45.69M)(28.38M)(5.75M)(10.55M)(19.53M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$14.2M
Other Current$2.0M
Total Current Assets$16.2M
Total Assets$16.2M

Analysis

Selected assets total $16.2M for Latest. The largest visible component is Cash & Equivalents at $14.2M, about 87.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
DEF 14ADEF 14A filingSep 11, 2026
PRE 14APRE 14A filingAug 25, 2026
10-QQuarterly reportAug 14, 2026
SC 13GSC 13G filingAug 14, 2026
8-KCurrent reportAug 14, 2026

How much cash does ANVS have?

Annovis Bio, Inc. (ANVS) reported $19.53M in cash and equivalents in fiscal 2025.

How much debt does ANVS carry?

Annovis Bio, Inc. (ANVS) reported $0.00 of total debt, with net debt of -$19.53M.